<p>This is a $249,723.49 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Solaris Vaccines, Inc. under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a "VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH DEVICE FOR PSORALEN-UVA INACTIVATION OF DENGUE VIRUS." The contract has a total small business set-aside and an ultimate completion date of January 20, 2025.</p>
<p>This is a $148,402.94 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sanaria, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for "Delivery System for Cryopreserved Eukaryotic Cell Vaccines" research and development work, with a completion date of January 10, 2019. The contract was set aside for small businesses.</p>
<p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>
This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
This is a $1,299,935.36 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Advanced Cooling Technologies Inc., a small business manufacturer based in Pennsylvania. The contract is a Phase II SBIR award for the development of a "PSORALEN-UV-A IRRADIATION BASED HIGH-THROUGHPUT PATHOGEN INACTIVATION DEVICE". The contract has a period of performance ending on November 1, 2027. This contract is set aside for small businesses. Advanced Cooling Technologies Inc. has a...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This is a $1,648,645.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc. under the Small Business Innovation Research (SBIR) Phase II program. The purpose of this contract is to focus on developing a T-cell activation protocol consistent with reporter cell viability, creating a proprietary reporter cell line, and gathering and benchmarking...
This is a $149,998.99 Phase I SBIR (Small Business Innovation Research) contract awarded by the Department of the Army Medical Command to Mainstream Engineering Corp, a for-profit manufacturer and research company. The contract, titled "PASSIVELY REGULATED CRYOGENIC (PARC) VIAL SYSTEM FOR VACCINE DISTRIBUTION AND ADMINISTRATION," is for research and development of a specialized cryogenic vial system to support vaccine distribution and administration. As a Phase I SBIR award, this...
This is a definitive, cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Public Health Vaccines LLC, a for-profit limited liability company. The purpose of this $101,433,355.76 contract modification is to exercise and fully fund Option 4/CLIN 0005 for the advanced research and development of an RVSV-MARV vaccine. The contract has an ultimate completion date of December 31, 2028 and was originally awarded on...
This is a $1,303,426.92 firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc., a small business biotechnology company. The contract is for sorting peripheral blood mononuclear cells from Lassa fever virus survivors to discover and produce monoclonal antibodies for assessment in in vitro and in vivo assays. The original solicitation was issued as a Request for Proposal (RFP) under NAICS code 541380, with a small business size standard of $19.0 million....